IE46614B1 - Preparation of 2-aryl-propionic acids by direct coupling utilizing a mixed magnesium halide complex - Google Patents

Preparation of 2-aryl-propionic acids by direct coupling utilizing a mixed magnesium halide complex

Info

Publication number
IE46614B1
IE46614B1 IE320/78A IE32078A IE46614B1 IE 46614 B1 IE46614 B1 IE 46614B1 IE 320/78 A IE320/78 A IE 320/78A IE 32078 A IE32078 A IE 32078A IE 46614 B1 IE46614 B1 IE 46614B1
Authority
IE
Ireland
Prior art keywords
aryl
solution
complex
bromo
magnesium
Prior art date
Application number
IE320/78A
Other versions
IE780320L (en
Inventor
Gary J Matthews
Robert A Arnold
Original Assignee
Syntex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/863,290 external-priority patent/US4144397A/en
Application filed by Syntex Corp filed Critical Syntex Corp
Publication of IE780320L publication Critical patent/IE780320L/en
Publication of IE46614B1 publication Critical patent/IE46614B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/19Acids containing three or more carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/14Monocyclic dicarboxylic acids
    • C07C63/15Monocyclic dicarboxylic acids all carboxyl groups bound to carbon atoms of the six-membered aromatic ring
    • C07C63/241,3 - Benzenedicarboxylic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of the formula aryl CH(CH3)COOMgX, in which aryl denotes 6-methoxy-2-naphthyl, 4-alkylphenyl or 4'-fluoro-4-biphenyl, and X denotes chlorine or bromine, and their etherates, are described. They are prepared by treating a solution of the corresponding arylmagnesium bromide with the solution of a complex of the formula CH3CH(Br)COOMgX in an aprotic solvent containing an ether. The compounds are important intermediates in the synthesis of known 2-arylpropionic acids of therapeutic importance.

Description

One of the most frequently employed synthetic methods for the preparation of arylalkanoic acids has been the coupling of an aryl organometallic reagent with a haloalkanoic acid derivative such as a haloalkanoic acid ester. This method has proven to be of particular importance for the preparation of the valuable anti-inflammatory agent 2-(6-methoxy-2-naphthyl)propionic acid. In particular, for the preparation of this compound, couplings involving an alpha-halopropionie acid ester and 2-(6-methoxynaphthyl)copper (U.S. 3,658,863), zinc (U.S. 3,663,584) and cadmium (U.S. 3,658,858 and 3,694,476) reagents have· been utilized. One disadvantage of these procedures is that the organometallic reagent used for the coupling must be prepared from the corresponding Grignard reagent, thus necessitating an additional chemical reaction, additional reagents, and so forth.
In German OLS 2145650 the direct coupling of aryl magnesium halides with potassium 2-iodopropionate was described. More recently, in U.S. 3,959,364, it was shown that an improved direct coupling could be effected by reaction of an aryl Grignard reagent with the lithium, sodium, magnesium or calcium salts of 2-bromopropionic acid of the structure CH3CH(X)COM wherein X is bromo and M stands for OLi, ONa, O(Mg)jy2or °(Ca)·^ ( cf· Table 11 °f U.S. 3,959,364). However, it has been found that the preparation of 2-aryl-proplonic acids, especially the valuable compound 2-(6-methoxy-2-naphthyl)propionic acid, by this method suffers from a number of inherent I disadvantages including preparation of halopropionate salt in the aprotic solvent media that must be employed for the coupling reaction, leading to poor results for large scale preparations. it would, therefore, be of extreme value to have a coupling process utilizing an aryl Grignard reagent and a suitable halopropionic acid derivative which afforded the desired 2-aryl-propionic acids easily and in reproducible high yield and purity and was readily adaptable to large scale commercial production.
The present invention is related to the preparation of known valuable anti-inflammatory agents, more specifically 2-aryl-propionic acids such as 2-(6-methoxy-2-naphthyl)propionic acid which is described in U.S. 3,904,682. More specifically, the present invention concerns a novel process for the preparation of these valuable therapeutic agents and novel intermediates for use in that process.
Still more specifically, the present invention concerns a direct coupling process whereby a desired aryl magnesium bromide is coupled with a magnesium halide complex of alpha-bromopropionic acid, in high yield, to afford the corresponding 2-aryl-propionic acid. All reference to 2-aryl-propionic acids in the specification and the appended claims is to the racemic form of these compounds.
The 2-aryl-propionic acids whose preparation is within the scope of the present invention are those wherein the aryl moiety is -346614 6-methoxy~2-naphthyl, i.e. 2-(6-methoxy-2-naphthyl)~ propionic acid; 4-alkylphenyl, wherein alkyl refers to straight and branched chain saturated hydrocarbon groups having from one to four carbon atoms, e.g., 2-(4-methylphenyl)propionic acid, 2-(4-isopropylphenyl)propionic acid and 2-(4-isobutylphenyl)propionic acid; and 4'-fluoro-4-biphenvl, i.e., 2-(4'-fluoro-4-biphenyl)propionic acid.
As mentioned above, the prior art U.S. Patent 3,959,364 describes the preparation of arylalkanoic acids by the direct coupling of an aryl Grignard reagent with the Na, Li, Ca jl/2 and M9 sa-'-ts alpha-bromopropionic acid.
It has now been found that, surprisingly, an improved coupling reaction results if one employs, instead of one of the aforementioned salts, a magnesium halide complex of alpha-bromopropionic acid, that is, a species of the formula CH3CH(Br)COOMgX wherein X is chloro or bromo. In fact, a direct comparison of the magnesium salt of alpha-bromopropionic acid (prepared by both methods disclosed in U.S. 3,959,364) and the novel complex hereof demonstrates a remarkable difference in yield of final products obtained (about a 2-fold difference) and is set forth in further detail in the Examples. It is an additional advantage of the present coupling process that its yields are not affected by the preparation of the magnesium halide complex to the extent the yields of the coupling process of U.S. 3,959,364 are affected by the method of preparation of the 2-bromopropionate salt (cf.
U.S. 3,959,364 column 3 lines 10 and 11). -446614 The magnesium halide complex of alpha-bromopropionic acid may be prepared by treatment of the free acid with a suitable Grignard reagent. While the nature of the hydrocarbon moiety of the Grignard reagent is not critical it is preferred that the free hydrocarbon formed in the reaction of alpha-bromopropionic acid with the Grignard reagent does not interfere with the coupling step or workup. As a consequence, Grignard reagents derived from hydrocarbons that are gaseous or liquid at reaction ?0 temperatures are particularly suitable, for example alkyl magnesium Grignards with 1 to 12 carbon or aryl magnesium Grignards with 6 to 9 carbon atoms. Specific Grignard reagents that may be employed for this purpose are methyl magnesium chloride, methyl magnesium bromide, ethyl magnesium chloride, ethyl magnesium bromide, isopropyl magnesium chloride, phenyl magnesium chloride, and ο-, m-, or p-tolyl magnesium chloride, and the like. Methyl magnesium chloride and methyl magnesium bromide are particularly preferred inasmuch as they are readily commercially available, inexpensive, arid lead to the formation of methane gas which escapes from the reaction mixture and does not interfere during reaction or workup. It has been found that, surprisingly, the addition of one of the aforesaid Grignard reagents to alpha-bromopropionic acid results primarily in formation of the aforementioned complex. Addition of the Grignard reagent across the carbonyl moiety of the carboxylic acid, a reaction which normally would be expected to occur to a large degree, appears to be minimal even when a molar excess of Grignard reagent is employed. -546614 Preparation of the magnesium halide complex is carried out in an aprotic solvent medium comprising an ether such as diethylether, tetrahydrofuran, 1,2-dimethoxyethane or di-(n-butyl)ether. The solvent medium may include other aprotic solvents such as aromatic hydrocarbons, e.g., benzene or toluene. A preferred solvent medium for complex preparation is tetrahydrofuran. While the order of addition of reagents is not narrowly critical it is normally preferred to add the Grignard reagent to the alpha-bromopropionic acid.
The Grignard reagent, in solution, is preferably from about 1 to 4 M, most preferably from about 2 to about 3 M. A final complex solution for use in the direct coupling step of from about 1 to about 2M, preferably from about 1.0 to 1.5 M is desirable. The temperature of the complex formation step is normally maintained between about -20 and +30°C, preferably between about -10 and +20°C.
The coupling reaction itself is performed by contacting a solution of the magnesium halide complex of alpha-bromopropionic acid with a solution of the aryl magnesium bromide, each solution being in an aprotic organic solvent medium comprising an ether. Suitable solvent media for the reaction include organic ethers and mixtures of organic ethers with aromatic hydrocarbons as mentioned above for the complex formation step. A particularly preferred solvent medium for the coupling reaction is tetrahydrofuran. It is preferred that the aryl magnesium bromide solution be between 0.5 and 2 M, most preferably about 1.0 M. The reaction will take place under substantially anhydrous conditions.
The coupling process itself may be carried out over a temperature range of from about 0 to about +100eC, preferably between about 10 and 60°C. It is particularly preferred to allow the temperature to gradually rise during the addition stage up to about 40-60°C and then to return to ambient temperature until the desired degree of reaction has been attained.
Although the coupling reaction may be conducted utilizing the reagents in varying proportions to one another it is preferred that approximately equimolar amounts of the mixed magnesium halide complex and the aryl Grignard reagent be utilized. Preferred ratios are from about 0.9:1.1 to 1.1:0.9 complex : Grignard reagent.
The reaction may be performed by conveniently contacting the two reagents in the solvent medium in any manner conventional in the art. However, it is particularly preferred to add the mixed magnesium halide complex to the Grignard reagent and to keep these reagents in intimate admixture until the desired reaction is essentially complete.
The time necessary for performance of the desired reaction will, of course, be influenced by the particular choice of reagents, solvents and reaction temperature and will ordinarily be adjusted by the skilled practitioner to allow for the optimum production of the desired product. Generally however such reaction time will be in the range of from about 10 minutes to about 20 hours, usually being in the range of from about 1 to about 5 hours.
After the coupling reaction has proceeded to the desired state of completion the reaction mixture -746614 containing the coupled complex ArylCH(CH3)COOMgX is then acidified with an acid, preferably a dilute acid, and most preferably a dilute aqueous mineral acid such as hydrochloric acid or sulfuric acid, in the conventional manner for Grignard reactions. The free 2-aryl-propionic acid product may then be isolated and purified from the quenched reaction mixture by conventional means such as extraction with aqueous alkali (e.g. aqueous sodium or potassium hydroxide), separation of the aqueous alkaline phase from the organic phase and acidification of the aqueous alkaline phase to free the desired acid, which may optionally be extracted into an organic solvent or directly purified in the usual manner such as by washing and/ot crystallization.
If desired, the crude reaction product may be directly converted into a pharmaceutically acceptable derivative of the carboxylic acid, such as a salt, ester or amide thereof, or resolved into optical isomers.
The process of the present invention is easily and conveniently performed on a large scale and affords yields of purified product in the 50-75% range.
The following examples are illustrative of the process of the present invention. They are not intended to limit the spirit or scope of the invention in any manner. -846614 PREPARATION 1 Preparation of 2-(6-methoxynaphthyl)magnesium bromide. 2-Bromo-6-methoxynaphthalene (23.7 g., 0.1 mole) is dissolved in toluene (30 ml.) and tetrahydrofuran (40 ml.) with heating. This solution is then added over a 10-15 minute period to an excess of magnesium metal (3 g., 0.12 moles), toluene (15 ml.) and tetrahydrofuran (15 ml.) under a nitrogen atmosphere. The reaction mixture is then cooled and stirred for an additional hour at 25-30°C. The reaction mixture is then transferred away from the excess magnesium to a clean, dry vessel under nitrogen and stored at 10°C to afford a 1.0 M Grignard reagent.
Proceeding in a similar manner, the Grignard reagent may be prepared using tetrahydrofuran as the sole solvent.
Similarly, by utilizing less solvent, a more concentrated Grignard reagent, e.g., 1.5 M, may be prepared. -9PREPARATION 2 Mixed magnesium halide complex of alpha-bromopropionic acid. .3 G. (0.1 mole) of alpha-bromopropionic acid and 40 5 ml. of toluene are cooled to 10°C and a solution of 50 ml. of 2 M methylmagnesium bromide in tetrahydrofuran/toluene (1:1) is then added slowly, maintaining the temperature at 10-20°C during the addition time of 15-20 minutes. The reaction mixture is then stirred at 5°C for an additional minutes to afford a 1.1 M solution of the complex.
Proceeding in a similar fashion, the mixed magnesium halide complex may be prepared utilizing tetrahydrofuran as the sole solvent.
Similarly, methylmagnesium bromide may be replaced by 15 other Grignard reagents such as methylmagnesium chloride, isopropylmagnesium chloride and phenylmagnesium chloride, in concentrations varying from about! to about 4 M.
The mixed magnesium chloride complex of alpha-bromopropionic acid (prepared as described above using 3 M 20 CH-jMgCl in tetrahydrofuran) was isolated in crystalline form as its tetrahydrofuran monoetherate after distilling tetrahydrofuran from a tetrahydrofuran solution and was analyzed: mp 147-155°C; ir (KBr) 1625, 1450, 1420, 1372, 1291, 1200, 1070, 1030, 988, and 890 cm1; nmr (D20) delta 1.8 (multiplet, 7) 3.7 (multiplet, 4), and 4.35 ppm (quartet, J=7). Elemental analysis calculated for C7H12BrClMgO3: Mg, 8.57%; Cl, 12.49%.
Found: Mg, 8.63%, Cl, 12.97%. -1046614 PREPARATION 3 Preparation of aryl magnesium bromides 0.025 Moles of aryl bromide is dissolved in tetrahydrofuran (18 ml.). This solution is then added to an excess of magnesium metal (3 g, 0.02 moles), and tetrahydrofuran (7 ml.) under a nitrogen atmosphere. The temperature is maintained at 50-60°c with cooling during the addition period of 10-15 minutes. The reaction mixture is then transferred away from the excess magnesium to a clean dry vessel under nitrogen and stored at 10°C to afford a 1.0 M Grignard reagent. The following Grignard reagents were prepared in this manner: 2- (6-methoxyn'aphthyl)magnesium bromide 4-(4'-fluorobiphenyl)magnesium bromide 1-(4-isopropylphenyl)magnesium bromide 1- (4-isobutylphenyl)magnesium bromide 1- (4-methylphenyl)magnesium bromide -11PREPARATION 4 A. Preparation of the mixed magnesium halide complex of alpha-bromopropionic acid.
Alpha-bromopropionic acid (3.8 g., 0.025 moles) is dissolved in tetrahydrofuran (8 ml.), and the solution cooled to -10°C. To this solution is added 3 M methylmagnesium chloride in tetrahydrofuran (8 ml.) over a 15minute period while maintaining the temperature at -10° to 0ec. This affords a 1.1 M molar solution of the complex which is stored at 0°C or below until use.
Similarly, replacing 3 M methylmagnesium chloride with 1 M methylmagnesium bromide, the corresponding magnesium bromide complex may be prepared. Β» Preparation of the magnesium salt of alpha-bromopropionic acid Alpha-bromopropionic acid (3.8 g., 0.025 moles) is dissolved in methanol (6 ml.) and the solution is cooled to -10°C. To this is added a 0.5 M magnesium methoxide in methanol solution (25 ml.) over a ten-minute period while maintaining the temperature at -10° to O°C. Methanol is then removed under reduced pressure to yield the solid salt which is dried in vacuo at 50°C for twelve hours to yield the dry magnesium salt (4.1 g., 0.0125 moles, purity 97.2%). This salt is dissolved in 19 ml. of tetrahydrofuran for the coupling reaction.
EXAMPLE 1 A. The solution of complex from Preparation 2 is added slowly to the Grignard solution from Preparation 1, maintaining the temperature at 15-20°C during the addition time of 10-15 minutes. The reaction mixture is allowed to warm up to room temperature and then stirred for two hours. The reaction mixture is then cooled in an ice bath and a solution of 20 ml. of 12 N hydrochloric acid and 150 ml. of water is added. After stirring for 5 minutes, the twophase system is filtered and the filter cake is was'hed with 55 ml. of toluene and 50 ml. of water. The organic phase is extracted with 10% potassium hydroxide solution (2 x 150 ml.) and the combined basic extracts are washed with toluene (30 ml.) and neutralized with 12 N hydrochloric acid to pH 1. The white solid 2-(6-methoxynaphthyl)propionic acid is filtered under vacuum and dried at 55°C in vacuo to afford 15.2 grams (66%), m.p. 149.5-153.5°C.
B. Alternatively, after filtration, the organic phase may be extracted with 10% potassium hydroxide solution (2 x 150 ml.) which is washed with toluene (30 ml.) and filtered. 15 Ml. of methanol and 12 ml. of toluene are added, then sufficient 12 N hydrochloric acid to bring the pH to between 4 and 5. The resulting slurry is then heated to reflux for 1 hour, cooled and filtered. The precipitate is washed with water (20 ml.) toluene (2 x 3 ml.) and hexane (2x3 ml..) and dried at 55°C in vacuo to yield 15.0 g. (65.1%) of product, m.p. 154.5-155°C. -13EXAMPLE 2 Ml. of a 1.5 M solution of the mixed magnesium chloride complex of alpha-bromopropionic acid in tetrahydrofuran (prepared utilizing 3 M methylmagnesium chloride) is slowly added to a cooled (10°C) solution of 1.5 M 2-(6-methoxynaphthyl)magensium bromide in tetrahydrofuran (67 ml.) at a rate such that the temperature is held at 55°C or below. The resulting slurry is stirred at 50°C for one hour and then heated to reflux, allowing 30-40? of the tetrahydrofuran to distill off. The reaction mixture is cooled to 50°C, 30 ml. of toluene is added and the reaction mixture is quenched with aqueous hydrochloric acid and worked up as in Example IB to afford 2-(6-methoxy-2-naphthyl)propionic acid, m.p. 156-157°C, in 73% yield.
EXAMPLE 3 A. The magnesium salt of alpha-bromopropionic acid, i.e. [CH^CH(Br)COO]£Mg, was prepared by reacting the acid with 1/2 molar equivalent of magnesium carbonate, followed by drying the salt at 60eC in vacuo.
Replacement of the mixed magnesium chloride complex used in Example 2 with this salt resulted in a 34.7? yield of product.
B. The salt of part A was also prepared using 1/2 molar equivalent of magnesium methoxide, methanol being removed as an azeotrope. Use of the salt in the procedure of Example 2 afforded a 43.0% yield of product. -1446614 EXAMPLE 4 Example 3A was repeated, except that 1/2 molar equivalent of anhydrous magnesium chloride was added to the magnesium salt prior to the coupling reaction. A 5,1% yield of product was obtained.
EXAMPLE 5 The procedure of Example 3B was repeated except that equimolar amounts of alpha-bromopropionic acid and magnesium methoxide were employed. The yield of product obtained was 35.1%. -1546614 EXAMPLE 5 Comparative coupling reactions using mixed magnesium halide complexes and Mg ^/2 salts The following coupling reactions, (on the scale indicated below) were carried out utilising both the mixed magnesium chloride complex of alpha-bromopropionic acid (prepared as in Preparation 4A) or the magnesium salt of alpha-bromopropionic acid (prepared as in Preparation 4B) with the corresponding Grignard reagent (prepared as in Preparation 3). The procedure (illustrated for a 0.025 mole scale) is as follows: The 1.0 M solution of aryl magnesium bromide is cooled to 10°C and the solution of either the magnesium salt or magnesium chloride complex in tetrahydrofuran is added over a five-minute period while maintaining the temperature at 10“ to 55°C. The reaction mixture is then stirred at 25-30°C for two hours. The reaction mixture is then cooled to 10“C and a solution of 12N hydrochloric acid (10 ml.) and water (50 ml.) is added. Toluene (50 ml.) is then added and the aqueous phase is separated and discarded. The organic phase is extracted twice with 10% potassium hydroxide (50 ml.). The basic extracts are combined and neutralized with hydrochloric acid to give a precipitate which is filtered and dried at 50°C.
The results are presented in the following table: -16Η Τ3 (Ο rd 3 Φ +» ·Η ϋ >< (Ο Φ Τ5 Μ ϋ TJ U rd Φ •Η >ι ο*Ρ Ο X Φ +) rd f-4 Gj φ ε ω ο ο ΓΝ \<Η rd U Cn cn s s T3 Ρ (Ο G Cn •H P ϋ >1 P < ϋ φ •Η 44 u α ό 4J Φ P Φ tn d ε « G Ο Φ Cn •Η Ll •rd φ 42 Li rd ϋ »w ϋ tf •Η 0 ϋ 0 ω 4-» ϋ] 0 CO Φ •rd co O'-Ρ Φ G ·Η rd ••d 4-J 0 CO G ε 3 tf 3 σ ΰΡ Ν’ dP » dP dP dP dP O r- © 00 m VO Γ- Γ9 VO CN in cn 21 V 21 21 ύΡ ύΡ Φ O CO P • • 3 VO VO Gj σν co dP II II O in >1 >4 U U •P -P 0 o •P •id •rl CN 00 U 3 rd P P xr ro ο Ο -H 3 3 rd rd xf 42 0 Cb Gj 1 VO *· 1 VO * VO • 1 tf 1 P •P ro W m W co •P ϋ ϋ rd · rd • in ϋ tf 3 3 O O 3 2 TJ T5 • ♦ TJ 2 0 0 GjDS Gj 0i Gt 0 P P • 2 • 2 * P >i Gj Gj ε s ε s ε Qj,G σ\ η ο σν ιη 10 Γ*·» <Ν Ο Γ CN CO r-4 Ν’ rd Ο Π ιχ> CO Η (Ν m m ιη cn ιη ιη *-* ο ο. ε ο υ CN CN CN •P u- rd \ rd \ rd \ o ϋ rd u rd o rd Cn Cn Cn Cn Cn Cn £ 2 2 2 2 2 s •P c φ Ό I I i rd rd 1 rd rd >1 rd rd >1 >1 42 42 >1 >1 G G •Ρ Φ 44 Φ G Φ G Φ Φ Φ Φ Φ 42 TJ 42 TJ Φ TJ Φ TJ 42 TJ 42 tj Gj-«d GtH X! ‘fd 42 ·Ρ Gj’fd Qj‘P tf ε tf ε Gj ε Gj ε rd ε rd 6 G 0 G 0 •Η 0 •Η 0 >1 0 >ι 0 >1 P >1 Ρ 43 Ρ 43 Ρ Gj Ρ Gj Ρ X 43 ΧΛ 0 43 0 43 0 43 0 43 0 0 Ρ Ρ · Ρ Ρ λ ε 42 ε ο ε ο ε Gj ε Gj S •Ρ 3 44 3 3 3 3 3 0 3 0 3 Φ ·Η φ ‘Η rd ‘Η rd ·Η W ·Η CO ‘rd ε φ ε φ Md Φ νρ Φ •rd CO •rd CO 1 Φ 1 Φ 1 Φ 1 Φ 1 Φ 1 Φ VO G νο C χί G χί G Ν* G N* G —’ tn Cn Cn χ- tn *- cn tn 1 tf 1 tf 1 tf 1 tf 1 tf 1 tf «ν ε cn ε ν’ ε ν’ ε Η ε η ε -Ρ C (0 4-> (Ο 4-» <0 σ co (0 φ CO Φ Φ co Φ φ Φ rd rd Φ Φ rd rd 0 0 rd rd 0 0 ε ε 0 0 s ε in in ε ε Ol CN CN CN in in rd rd o o © o O © © o o © φ JZ •Ρ 6 614 It can be seen from the above, that in each instance a higher yield (approximately 2-fold) of greater purity product was obtained from the mixed magnesium chloride complex.
Xn a similar manner, comparable results may be achieved for the preparation of the following 2-arylpropionic acids: 2-(4-isobutylphenyl)propionic acid; 2-(4-methylphenyl)propionic acid.
If the above procedure is interrupted prior to quenching with aqueous acid, and the solvent is removed in vacuo, the coupled magnesium halide complexes, ArylCH(CH3)COOMgX or etherates thereof may be isolated.
The mixed magnesium chloride complex of 2-(6-methoxy-2naphthvl)propionic acid as its tetrahydrofuran monoetherate (98.1% purity) exhibits the following properties: m.p. 113°C (dec.); ir (KBr disc) 1600, 1450, 1410, 1260, 1210, 1155, 1025, 923, 885, 850, 805 and 750 cm-1; nmr (DMSO-dg) delta (TMS) 1.4 (doublet, 2H), 1.8 (multiplet, 4H), 3.6 (multiplet, 5H), 3.9 (singlet, 3H), 7.5 (multiplet, 6H) ppm.

Claims (26)

1. A complex compound of the formula CHgCH(Br)C00MgX or an etherate thereof, wherein X is chloro or bromo.
2. The complex compound CH 3 CH(Br)C00MgCl or an etherate thereof.
3. The tetrahydrofuran monoetherate of a complex of claim 1 or claim 2.
4. A magnesium halide complex of alpha-bromo-propionic acid, wherein the term halide refers to chloride or bromide, the complex being prepared by treatment of alpha-bromo-propionic acid with a Grignard reagent in an aprotic organic solvent containing an ether.
5. A complex of claim 4 wherein said Grignard reagent is a methyl magnesium halide selected from methyl magnesium chloride and methyl magnesium bromide.
6. A complex of claim 4 or claim 5 wherein said halide is a chloride.
7. A complex of any one of claims 4 to 6 wherein said ether comprises tetrahydrofuran.
8. A process which comprises contacting a solution of an aryl magnesium bromide, wherein the aryl is 6-methoxy-2-naphthyl, 4-alkylphenyl where the alkyl group has 1 to 4 carbon atoms, or 4'-fluoro-4-biphenyl, with a solution of a complex of any one of claims 1 to 7, each said solution being in an aprotic organic solvent medium comprising an ether, to produce the compound CH 3 CH(Ar)C00MgX or an etherate thereof, wherein Ar is an aryl group as defined above and X is chloro or bromo.
9. A process which comprises contacting a solution of an aryl magnesium bromide, wherein the aryl is 6-methoxy-2-naphthyl, 4-alkylphenyl where the alkyl has 1 to 4 carbon atoms, or 4'-fluoro-4biphenyl, with a solution of an alpha-bromo-propionic acid magnesium chloride or bromide complex, each said solution being in an aprotic organic solvent medium comprising an ether, to produce the compound CH 3 CH(Ar)C00MgX or an etherate thereof where the aryl is as defined above and X is chloro or bromo.
10. A process which comprises: (a) contacting a solution of an aryl magnesium bromide, wherein the aryl is 6-methoxy-2-naphthyl, 4-alkylphenyl where the alkyl has 1 to 4 carbon atoms, or 4'-fluoro-4-biphenyl, with a solution of a complex of any one of claims i to 7, each said solution being in an aprotic organic solvent medium comprising an ether, and (b) acidifying the reaction mixture from (a) to produce the corresponding 2-aryl propionic acid.
11. A process which comprises: (a) contacting a solution of an aryl magnesium bromide, wherein the aryl is 6-methoxy-2-naphthyl, 4-alkylphenyl where the alkyl has 1 to 4 carbon atoms, or 4'-fluoro-4-biphenyl, with a solution of an alpha-bromo-propionic acid magnesium chloride or bromide complex, each said solution being in an aprotic organic solvent medium comprising an ether, and (b) acidifying the reaction mixture from (a) to produce the corresponding 2-aryl propionic acid.
12. A process of any one of claims 8 to 11 wherein said solvent medium comprises tetrahydrofuran.
13. A process of any one of claims 8 to 12 performed at a temperature betv/een 10 and 60°C.
14. A process of any one of claims 8 to 13 wherein said aryl magnesium bromide solution is 0.5 to 2.0 molar and said complex solution is 1.0 to 2.0 molar. 4 6 6 1 4
15. A process of any one of claims 8 to 14 wherein said aryl is 6-methoxy-2-naphthyl.
16. A process according to claim 9 or claim 11 wherein a 0.5 to 2.0 molar solution of 2-(6-methoxynaphthy1)magnesium bromide in 5 tetrahydrofuran is contacted with a 1.0 to 2.0 molar solution of alpha-bromo-propionic acid magnesium chloride or bromide complex in tetrahydrofuran, at a temperature of between 0 and 100°C.
17. A process according to any one of claims 8 to 14 wherein said aryl is 4'-f1uoro-4-biphenyl. 10
18. A process according to any one of claims 8 to 14 wherein said aryl is 4-isopropylphenyl.
19. A process according to any one of claims 8 to 14 wherein said aryl is 4-isobutylphenyl.
20. A process according to any one of claims 8 to 11, substantially 15 as described herein.
21. A process for preparing a complex of any one of claims 1, 2 and 3 which comprises reacting alpha-bromo-propionic acid with an appropriate Grignard reagent in an aprotic organic solvent comprising an ether. 20
22. A process according to claim 21 wherein said Grignard reagent is methyl magnesium chloride or methyl magnesium bromide.
23. A process according to claim 21 substantially as described herein.
24. The compound Aryl CH(CH 3 )COOMgX or an etherate thereof, wherein aryl is 6-methoxy-2-napthyl, 4 '-fluoro-4-biphenyl or 4-alkylphenyl where alkyl has 1 to 4 carbon atoms, ahd X is bromo or chloro. 5
25. The compound of claim 24wherein aryl is 6-methoxy-2naphthyl and X is chloro.
26. The tetrahydrofuran monoetherate of the compound of claim 24 or 25.
IE320/78A 1977-02-16 1978-02-14 Preparation of 2-aryl-propionic acids by direct coupling utilizing a mixed magnesium halide complex IE46614B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76907077A 1977-02-16 1977-02-16
US05/863,290 US4144397A (en) 1977-02-16 1977-12-19 Preparation of 2-aryl-propionic acids by direct coupling utilizing a mixed magnesium halide complex

Publications (2)

Publication Number Publication Date
IE780320L IE780320L (en) 1978-08-16
IE46614B1 true IE46614B1 (en) 1983-08-10

Family

ID=27118118

Family Applications (1)

Application Number Title Priority Date Filing Date
IE320/78A IE46614B1 (en) 1977-02-16 1978-02-14 Preparation of 2-aryl-propionic acids by direct coupling utilizing a mixed magnesium halide complex

Country Status (18)

Country Link
CH (3) CH640499A5 (en)
DD (3) DD145107A5 (en)
DK (1) DK156898C (en)
ES (1) ES467037A1 (en)
FI (1) FI64571C (en)
HK (2) HK25483A (en)
HU (2) HU183210B (en)
IE (1) IE46614B1 (en)
IL (1) IL54019A (en)
IT (1) IT1107880B (en)
MY (2) MY8400040A (en)
NO (1) NO145435C (en)
NZ (1) NZ186472A (en)
PL (1) PL108144B1 (en)
PT (1) PT67654B (en)
SE (3) SE430155B (en)
SU (2) SU1003749A3 (en)
YU (3) YU41427B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8915531D0 (en) * 1989-07-06 1989-08-23 Ass Octel Alkaline earth,transition and lanthanide metal inorganic salt complexes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459084A (en) * 1973-05-24 1976-12-22 Boots Co Ltd Preparation of arylalkanoic acid

Also Published As

Publication number Publication date
CH640499A5 (en) 1984-01-13
SU963462A3 (en) 1982-09-30
IL54019A0 (en) 1978-04-30
MY8400039A (en) 1984-12-31
PT67654A (en) 1978-03-01
IT7867279A0 (en) 1978-02-10
PL108144B1 (en) 1980-03-31
FI780417A (en) 1978-08-17
FI64571B (en) 1983-08-31
CH640500A5 (en) 1984-01-13
CH640498A5 (en) 1984-01-13
YU58783A (en) 1983-12-31
SE8201458L (en) 1982-03-09
IE780320L (en) 1978-08-16
PL204667A1 (en) 1978-12-04
YU58883A (en) 1983-12-31
FI64571C (en) 1983-12-12
SE8201459L (en) 1982-03-09
SE453094B (en) 1988-01-11
SE7801648L (en) 1978-08-16
SU1003749A3 (en) 1983-03-07
DD148212A5 (en) 1981-05-13
YU43302B (en) 1989-06-30
DK156898C (en) 1990-03-12
MY8400040A (en) 1984-12-31
HU183210B (en) 1984-04-28
DD145107A5 (en) 1980-11-19
SE453093B (en) 1988-01-11
NZ186472A (en) 1979-08-31
HK25483A (en) 1983-08-12
IT1107880B (en) 1985-12-02
NO145435C (en) 1982-03-24
NO780524L (en) 1978-08-17
NO145435B (en) 1981-12-14
DK156898B (en) 1989-10-16
HU179309B (en) 1982-09-28
DD137099A5 (en) 1979-08-15
DK64578A (en) 1978-08-17
IL54019A (en) 1981-06-29
YU32978A (en) 1983-06-30
ES467037A1 (en) 1978-11-01
YU42843B (en) 1988-12-31
YU41427B (en) 1987-06-30
SE430155B (en) 1983-10-24
PT67654B (en) 1979-07-19
HK25383A (en) 1983-08-12

Similar Documents

Publication Publication Date Title
US4144397A (en) Preparation of 2-aryl-propionic acids by direct coupling utilizing a mixed magnesium halide complex
EP0071006B1 (en) Tetrahydronaphthalene derivatives and their production
US4665212A (en) Process for preparing 2-(4-hydroxyphenoxy) alkanoic acid compounds
KR100362868B1 (en) Method for preparing alkylated aromatic carboxylic acid and acyl halide
IE46614B1 (en) Preparation of 2-aryl-propionic acids by direct coupling utilizing a mixed magnesium halide complex
JPS5828877B2 (en) New 2,6-dimethoxy-4-substituted phenyl disubstituted phosphates
US5190671A (en) Process for the synthesis of monohaloalkanoylferrocenes
JPH11501314A (en) Method for preparing esters of stilbene dicarboxylic acid
CA1115722A (en) Preparation of 2-aryl-propionic acids by direct coupling utilizing a mixed magnesium halide complex
US4675449A (en) Process for producing 6-hydroxy-2-naphthones
US4761508A (en) 1,1-(3-ethylphenyl)phenylethylene and method for preparing it
JP2531708B2 (en) Method for separating and purifying 3- (3,5-ditertiary butyl-4-hydroxyphenyl) propionic acid ester
US3708530A (en) Benzylhalide carbonylation process
JP3563424B2 (en) Method for producing 4H-pyran-4-one
US2623065A (en) Methods for producing alkoxynaphthoylalkanoic acids
FI82442C (en) Process for the preparation of 2-arylpropionic acid-magnesium halide complexes and its use in the preparation of 2-arylpropionic acid
JP3962467B2 (en) Process for producing 1,4-dihydroxy-2-naphthoic acid aryl esters
JP3830749B2 (en) Process for producing optically active 4,4,4-trifluoro-3-hydroxybutanoic acid aryl ester derivative
JP3569877B2 (en) Method for producing m-substituted-α-hydroxymethylstyrene derivative and 3-chloro-α-bromostyrene
KR100322237B1 (en) Process for preparing α-ketocarboxylic acid derivatives
JPH06135937A (en) Production of 5,5-disubstituted hydantoin
WO1997034860A1 (en) A PROCESS FOR THE PREPARATION OF α-ARYLPROPIONIC ACIDS AND THE INTERMEDIATES THEREOF
JPH0352885A (en) Production of thiophenedicarboxylic acid diester
FR2863613A1 (en) New 3-substituted hydroxy-phenylboronic acid derivatives, useful in synthesis of non-steroidal Vitamin D3 analogs by Suzuki coupling to trifluoromethylsulfonyloxy-benzene derivative
JP2003113128A (en) New method for synthesizing ynolate anion

Legal Events

Date Code Title Description
MK9A Patent expired